Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis

Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more se...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniel B. Spielman, Jonathan Overdevest, David A. Gudis
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2020
Materias:	Aspirin exacerbated respiratory disease AERD Samter's Triad Olfaction hyposmia Endoscopic sinus surgery Otorhinolaryngology RF1-547 Surgery RD1-811
Acceso en línea:	https://doaj.org/article/f696096fb6b14f6e888da5b9b987cf5d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f696096fb6b14f6e888da5b9b987cf5d
record_format	dspace
spelling	oai:doaj.org-article:f696096fb6b14f6e888da5b9b987cf5d2021-12-02T13:57:40ZOlfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis2095-881110.1016/j.wjorl.2020.07.001https://doaj.org/article/f696096fb6b14f6e888da5b9b987cf5d2020-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881120301013https://doaj.org/toc/2095-8811Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.Daniel B. SpielmanJonathan OverdevestDavid A. GudisKeAi Communications Co., Ltd.articleAspirin exacerbated respiratory diseaseAERDSamter's TriadOlfactionhyposmiaEndoscopic sinus surgeryOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 6, Iss 4, Pp 207-213 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Aspirin exacerbated respiratory disease AERD Samter's Triad Olfaction hyposmia Endoscopic sinus surgery Otorhinolaryngology RF1-547 Surgery RD1-811
spellingShingle	Aspirin exacerbated respiratory disease AERD Samter's Triad Olfaction hyposmia Endoscopic sinus surgery Otorhinolaryngology RF1-547 Surgery RD1-811 Daniel B. Spielman Jonathan Overdevest David A. Gudis Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
description	Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.
format	article
author	Daniel B. Spielman Jonathan Overdevest David A. Gudis
author_facet	Daniel B. Spielman Jonathan Overdevest David A. Gudis
author_sort	Daniel B. Spielman
title	Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_short	Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_full	Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_fullStr	Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_full_unstemmed	Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_sort	olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
publisher	KeAi Communications Co., Ltd.
publishDate	2020
url	https://doaj.org/article/f696096fb6b14f6e888da5b9b987cf5d
work_keys_str_mv	AT danielbspielman olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis AT jonathanoverdevest olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis AT davidagudis olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis
_version_	1718392295794933760

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis

Ejemplares similares